ClinicalTrials.gg
Drug

Dapagliflozin clinical trials

Also written Forxiga, Farxiga, BMS-512148 and BR3006.

studies test it
485
open now
117
in phase 3
132
first study started
2005

How each study uses dapagliflozin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the dapagliflozin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
8 Jan 2014 · FARXIGA · NDA 202293 (FDA, Drugs@FDA)
European Union
11 Nov 2012 · Forxiga · EMEA/H/C/002322 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dapagliflozin
241
Dapagliflozin 10mg Tab
60
Dapagliflozin 10 mg
32
Dapagliflozin 10mg
23
Dapagliflozin (DAPA)
16

Brand

Forxiga
71
Farxiga
54
Forxiga 10mg
5
Forxiga 10 mg
3
Farxiga 10 mg
3
FORXIGA 5mg
1

Development codes

BMS-512148
24
BR3006
2
BR3006A
2

In one entry with another drug

Given together, or one or the other

Dapagliflozin/Metformin
4
Baxdrostat/dapagliflozin
3
Baxdrostat CIN-107
3
Xigduo
3
Zibotentan/Dapagliflozin
2
Balcinrenone/dapagliflozin
2
Dapagliflozin + Metformin
2
Spironolactone + Dapagliflozin
2

Studies by the year they started

482 studies that test it; most in 2022 (54); 3 more planned to start later

Studies that test dapagliflozin, by start year
YearStudies
20052
20062
20075
20088
200912
201013
20114
20126
20131
201414
201527
201629
201721
201815
201926
202033
202143
202254
202341
202448
202542
202636

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
62
Phase 2
113
Phase 3
132
Phase 4
166
No phase
36

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 126 · Other 359

AstraZeneca (106) · The University of Texas Health Science Center at San Antonio (11) · Mansoura University (9) · University of Guadalajara (6) · Tanta University (5) · Ain Shams University (5) · University of Campinas, Brazil (5) · Assiut University (5)

Often tested with

Tested in the same studies.

Metformin (27) · Empagliflozin (20) · Saxagliptin (15) · Sitagliptin (10) · Semaglutide (9) · Pioglitazone (9) · ZD4054 (7) · Exenatide (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 4 phase 3 studies under way

Dapagliflozin is the comparator. A study of two new drugs counts under both.

  • 1Enavogliflozin · Daewoong Pharmaceutical Co. LTD.
  • 1HDM1002 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · next primary completion Feb 2027
Reaching primary completion within a year · 37, 11 in phase 3

Studies that test dapagliflozin, phase 3 first.

Studies

Open first, then newest update. How each study uses dapagliflozin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 485

See all 485 studies that test dapagliflozin →

Given beside what is tested · 43 — dapagliflozin is usual care or a partner of the new treatment

Showing 20 of 43.

As the comparator · 23 — what is tested is compared with dapagliflozin

Showing 20 of 23.

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call dapagliflozin · ClinicalTrials.gg INT005279

  • MeSH (NLM) C529054dapagliflozinConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 1ULL0QJ8UCDAPAGLIFLOZINConfirmed FDA, NLM, Wikidata
  • RxNorm 1488564Confirmed FDA, Wikidata
  • Wikidata Q409898dapagliflozinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C78126DapagliflozinOne source FDA
  • DrugBank DB06292One source Wikidata

Also registered as dapagliflozin propanediol (UNII 887K2391VH · RxNorm 1486966).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.